Ex-Pharma Exec Cops To Insider Trading With Former CFO

By Bill Wichert (June 22, 2022, 7:36 PM EDT) -- The former head of corporate communications for Immunomedics admitted Wednesday in New Jersey federal court to engaging in an insider trading scheme in which the biopharmaceutical company's then-chief financial officer allegedly shared nonpublic information about a breast cancer drug with her while they were dating.

Lauren S. Wood, 33, of Washington, D.C., pled guilty before U.S. District Judge John Michael Vazquez to an information charging her with securities fraud, court records show. Her guilty plea comes more than a month after former Immunomedics CFO Usama Malik was charged in a three-count indictment over the purported scheme. In 2020, Gilead Sciences acquired Immunomedics...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!